Hofker M - Search Results

1

Atherosclerosis in APOE*3-Leiden transgenic mice: from proliferative to atheromatous stage.

Lutgens E, Daemen M, Kockx M, Doevendans P, Hofker M, Havekes L, Wellens H, de Muinck ED. Lutgens E, et al. Among authors: hofker m. Circulation. 1999 Jan 19;99(2):276-83. doi: 10.1161/01.cir.99.2.276. Circulation. 1999. PMID: 9892595

2

Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice.

van Vlijmen BJ, van den Maagdenberg AM, Gijbels MJ, van der Boom H, HogenEsch H, Frants RR, Hofker MH, Havekes LM. van Vlijmen BJ, et al. Among authors: hofker mh. J Clin Invest. 1994 Apr;93(4):1403-10. doi: 10.1172/JCI117117. J Clin Invest. 1994. PMID: 8163645 Free PMC article.

3

Quantitative assessment of aortic atherosclerosis in APOE*3 Leiden transgenic mice and its relationship to serum cholesterol exposure.

Groot PH, van Vlijmen BJ, Benson GM, Hofker MH, Schiffelers R, Vidgeon-Hart M, Havekes LM. Groot PH, et al. Among authors: hofker mh. Arterioscler Thromb Vasc Biol. 1996 Aug;16(8):926-33. doi: 10.1161/01.atv.16.8.926. Arterioscler Thromb Vasc Biol. 1996. PMID: 8696955

4

Elevated levels of chylomicron- and VLDL-remnants leads to atherosclerosis in apoE transgenic mice.

van Vlijmen BJ, van Ree JH, Frants RR, Hofker MH, Havekes LM. van Vlijmen BJ, et al. Among authors: hofker mh. Z Gastroenterol. 1996 Jun;34 Suppl 3:113-5. Z Gastroenterol. 1996. PMID: 8767483 No abstract available.

5

Use of transgenic mice in lipoprotein metabolism and atherosclerosis research.

Havekes LM, van Vlijmen BJ, Jong MC, van Dijk KW, Hofker MH. Havekes LM, et al. Among authors: hofker mh. Prostaglandins Leukot Essent Fatty Acids. 1997 Oct;57(4-5):463-6. doi: 10.1016/s0952-3278(97)90429-4. Prostaglandins Leukot Essent Fatty Acids. 1997. PMID: 9430397

6

Characterization of atherosclerotic lesions in apo E3-leiden transgenic mice.

Leppänen P, Luoma JS, Hofker MH, Havekes LM, Ylä-Herttuala S. Leppänen P, et al. Among authors: hofker mh. Atherosclerosis. 1998 Jan;136(1):147-52. doi: 10.1016/s0021-9150(97)00196-2. Atherosclerosis. 1998. PMID: 9544741

7

Transgenic mouse models to study the role of APOE in hyperlipidemia and atherosclerosis.

Hofker MH, van Vlijmen BJ, Havekes LM. Hofker MH, et al. Atherosclerosis. 1998 Mar;137(1):1-11. doi: 10.1016/s0021-9150(97)00266-9. Atherosclerosis. 1998. PMID: 9568731 Review.

8

Effects of dietary fish oil on serum lipids and VLDL kinetics in hyperlipidemic apolipoprotein E*3-Leiden transgenic mice.

van Vlijmen BJ, Mensink RP, van 't Hof HB, Offermans RF, Hofker MH, Havekes LM. van Vlijmen BJ, et al. Among authors: hofker mh. J Lipid Res. 1998 Jun;39(6):1181-8. J Lipid Res. 1998. PMID: 9643349 Free article.

9

Binding of beta-VLDL to heparan sulfate proteoglycans requires lipoprotein lipase, whereas ApoE only modulates binding affinity.

de Beer F, Hendriks WL, van Vark LC, Kamerling SW, van Dijk KW, Hofker MH, Smelt AH, Havekes LM. de Beer F, et al. Among authors: hofker mh. Arterioscler Thromb Vasc Biol. 1999 Mar;19(3):633-7. doi: 10.1161/01.atv.19.3.633. Arterioscler Thromb Vasc Biol. 1999. PMID: 10073967

10

Progression and regression of atherosclerosis in APOE3-Leiden transgenic mice: an immunohistochemical study.

Gijbels MJ, van der Cammen M, van der Laan LJ, Emeis JJ, Havekes LM, Hofker MH, Kraal G. Gijbels MJ, et al. Among authors: hofker mh. Atherosclerosis. 1999 Mar;143(1):15-25. doi: 10.1016/s0021-9150(98)00263-9. Atherosclerosis. 1999. PMID: 10208477

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

267 results

Search Page

Filters